Thus, the decrease in u-ENaCγ in CKD patients and the increase in u-ENaCγ in healthy controls might be compensatory mechanisms due to an altered absorptive activity in NKCC2, but further studies are necessary to clarify this hypothesis.. This evidence concerns the gene SCNN1G and chronic kidney disease.